InvestorsHub Logo

arvitar

06/24/16 3:35 PM

#122565 RE: leifsmith #122564

So does the United States and most every other country, under Compassionate Use exemptions. It allows access to human investigational drugs under certain circumstances.

But that is entirely irrelevant to what is being discussed here.


What is being discussed here is that NNVC doesn't have a single IND-approved candidate, let alone a human investigational drug.

Hence, referring to their compounds as "drugs", is a nonstandard use of the term for a compound which might have no therapeutic effects whatsoever in humans, and might even be lethally toxic in humans, in spite of Seymour's "optimistic speculation" to the contrary.

Rawnoc

06/25/16 7:57 PM

#122585 RE: leifsmith #122564

"Every country wants to see the results of the Phase I and II studies before allowing a Phase III to start on their soil."

~~Seymour, 2011 interview